Acute Ischemic Stroke in Term Pregnancy Treated with Recombinant Tissue Plasminogen Activator
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Acute Ischemic Stroke in Term Pregnancy Treated with Recombinant Tissue Plasminogen Activator ; volume:12 ; number:Suppl 1 ; year:2020 ; pages:4-8
Case reports in neurology ; 12, Heft Suppl 1 (2020), 4-8
- Urheber
-
Aaron, Sanjith
Mannam, Pavitra Ratna
Shaikh, Atif
Mani, Arun Mathai
Bal, Deepti
Pandian, Jeyaraj Durai
- DOI
-
10.1159/000506763
- URN
-
urn:nbn:de:101:1-2020122323174659634298
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aaron, Sanjith
- Mannam, Pavitra Ratna
- Shaikh, Atif
- Mani, Arun Mathai
- Bal, Deepti
- Pandian, Jeyaraj Durai
Ähnliche Objekte (12)
Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
Genome response to tissue plasminogen activator in experimental ischemic stroke
Alleviating Recombinant Tissue Plasminogen Activator‐induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor
Die Anwendung von recombinant tissue plasminogen activator (rt-PA) in der Augenheilkunde
Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
Differences between predictive factors for early neurological deterioration due to hemorrhagic and ischemic insults following intravenous recombinant tissue plasminogen activator
Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses
Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report
Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Successful thrombolysis with recombinant tissue plasminogen activator after antagonizing dabigatran by idarucizumab: a case report
Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
Genome response to tissue plasminogen activator in experimental ischemic stroke
Alleviating Recombinant Tissue Plasminogen Activator‐induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor
Die Anwendung von recombinant tissue plasminogen activator (rt-PA) in der Augenheilkunde
Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
Differences between predictive factors for early neurological deterioration due to hemorrhagic and ischemic insults following intravenous recombinant tissue plasminogen activator
Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses
Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report
Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Successful thrombolysis with recombinant tissue plasminogen activator after antagonizing dabigatran by idarucizumab: a case report
Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
Genome response to tissue plasminogen activator in experimental ischemic stroke
Alleviating Recombinant Tissue Plasminogen Activator‐induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor
Die Anwendung von recombinant tissue plasminogen activator (rt-PA) in der Augenheilkunde
Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
Differences between predictive factors for early neurological deterioration due to hemorrhagic and ischemic insults following intravenous recombinant tissue plasminogen activator
Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses
Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report
Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden